insights_auto
Nega EDIT tushdi 2,71%?
Batafsil oʻrganishchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,51 US$
arrow_downward
-2,71%(-0,070) 1K
2,50 US$
arrow_downward
-0,40% (-0,0100)bedtimeYopilgandan keyin
Savdolar yopilgan: 21-okt, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,59 US$
Yuqori
2,60 US$
Past
2,50 US$
Bozor kapitali
385,49 mln
Oʻrtacha hajm
3,03 mln
Hajmi
1,14 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Ochish
2,59 US$
Yuqori
2,60 US$
Past
2,50 US$
Bozor kapitali
385,49 mln
Oʻrtacha hajm
3,03 mln
Hajmi
1,14 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Morningstar
·
11 daqiqa oldin
Innventure, Inc. (NASDAQ: INV) Securities Investigation: Investors Who Held Shares Since November 17, 2025, May Be Eligible to Seek Compensation - Stranch, Jennings & Garvey, PLLC
Moomoo
·
28 daqiqa oldin
31.3 Close
TradingView
·
26 daqiqa oldin
How Are Dow, S&P 500, Nasdaq Futures Trading After META, TSLA Earnings?
CNBC
·
11 soat oldin
Why the stock market’s fragile calm faces a major test starting Friday
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida